Herold Advisors, Inc.
- SEC CIK
- 0001891713
- Latest filing
- Jul 22, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by Herold Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −10,200−100.0% | Sold out | Holders |
| Q1 2022 | 10,200 | $55.0K | <0.1% | −8,300−44.9% | Reduced | Holders |
| Q4 2021 | 18,500 | $249.0K | 0.1% | +3,100+20.1% | Added | Holders |
| Q3 2021 | 15,400 | $276.0K | 0.1% | – | No prior filing | Holders |